Arteriovenous Malformation
13
2
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (13)
The Clinical Application of Peripheral Embolization Coil Systems in Arteriovenous Embolization Within the Peripheral Vasculature
Clinical Study on Emergency Treatment of Cerebral Arteriovenous Malformation Bleeding
Diagnostic Imaging of Vascular Malformations Using MSOT and ULM
Genetics of Arteriovenous Malformations
Evaluation of the Accuracy of the Vessel Navigator Tool for Catheterization of Supra-aortic Vessels - ARCHIBALD
Evaluation and Treatment of Patients Spinal Blood Vessel Abnormalities
Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB
Effect of Dexmedetomidine Combined With Sufentanil for Postoperative Intravenous Analgesia in Neurosurgery
Multicenter Validation of the AVICH Score
Hippocampal Radiation Exposure and Memory
Proton Radiotherapy for Primary Central Nervous System Tumours in Adults
Scalp Nerve Blocks for Post-Craniotomy Pain
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding